Cargando…

Glycoengineering of Natural Killer Cells with CD22 Ligands for Enhanced Anticancer Immunotherapy

[Image: see text] Adoptive transfer of immune cells is being actively pursued for cancer treatment. Natural killer (NK) cells, a class of cytotoxic immune cells, generally lack inherent selectivities toward cancer. To bestow tumor-targeting abilities and enhance anticancer efficacy, a new strategy i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xianwu, Lang, Shuyao, Tian, Yunpeng, Zhang, Jianghong, Yan, Xu, Fang, Zhihong, Weng, Jian, Lu, Na, Wu, Xuanjun, Li, Tianlu, Cao, Hongzhi, Li, Zhu, Huang, Xuefei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2020
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7099595/ https://www.ncbi.nlm.nih.gov/pubmed/32232138 http://dx.doi.org/10.1021/acscentsci.9b00956

Ejemplares similares

The Applications of Metabolic Glycoengineering
por: Ying, Liwei, et al.
Publicado: (2022)

Genetic glycoengineering in mammalian cells
por: Narimatsu, Yoshiki, et al.
Publicado: (2021)

Strategies for Glycoengineering Therapeutic Proteins
por: Dammen-Brower, Kris, et al.
Publicado: (2022)

Protein Glycoengineering: An Approach for Improving Protein Properties
por: Ma, Bo, et al.
Publicado: (2020)

Glycoengineering of pertuzumab and its impact on the pharmacokinetic/pharmacodynamic properties
por: Luo, Cheng, et al.
Publicado: (2017)

Glycoengineered anti-CD39 promotes anticancer responses by depleting suppressive cells and inhibiting angiogenesis in tumor models
por: Zhang, Haohai, et al.
Publicado: (2022)

Crystallizable Fragment Glycoengineering for Therapeutic Antibodies Development
por: Li, Wei, et al.
Publicado: (2017)

Impact of glycoengineering and antidrug antibodies on the anticancer activity of a plant‐made lectin‐Fc fusion protein
por: Dent, Matthew, et al.
Publicado: (2022)

Cyclopropene derivatives of aminosugars for metabolic glycoengineering
por: Hassenrück, Jessica, et al.
Publicado: (2019)

Glycoengineering of Therapeutic Antibodies with Small Molecule Inhibitors
por: Li, Shasha, et al.
Publicado: (2021)

Direct quality control of glycoengineered erythropoietin variants
por: Čaval, Tomislav, et al.
Publicado: (2018)

Applying Acylated Fucose Analogues to Metabolic Glycoengineering
por: Rosenlöcher, Julia, et al.
Publicado: (2015)

Labeling glycans on living cells by a chemoenzymatic glycoengineering approach
por: Almaraz, Ruben T., et al.
Publicado: (2017)

A novel cancer immunotherapy based on the combination of a synthetic carbohydrate-pulsed dendritic cell vaccine and glycoengineered cancer cells
por: Qiu, Lei, et al.
Publicado: (2015)

A critical role for natural killer cells in dendritic cell-based anticancer immunotherapy
por: McLellan, Alexander D
Publicado: (2014)

Cytoplasmic glycoengineering enables biosynthesis of nanoscale glycoprotein assemblies
por: Tytgat, Hanne L. P., et al.
Publicado: (2019)

A versatile design platform for glycoengineering therapeutic antibodies
por: Ludwig, Seth D., et al.
Publicado: (2022)

Erratum: A novel cancer immunotherapy based on the combination of a synthetic carbohydrate-pulsed dendritic cell vaccine and glycoengineered cancer cells
por: Qiu, Lei, et al.
Publicado: (2015)

Metabolic Glycoengineering: A Promising Strategy to Remodel Microenvironments for Regenerative Therapy
por: Li, Yi, et al.
Publicado: (2023)

Carbohydrate Conjugates in Vaccine Developments
por: Lang, Shuyao, et al.
Publicado: (2020)

IgG-Fc glycoengineering in non-mammalian expression hosts
por: Loos, Andreas, et al.
Publicado: (2012)

Glycoengineering Chinese hamster ovary cells: a short history
por: Donini, Roberto, et al.
Publicado: (2021)

Glycoengineering artificial receptors for microglia to phagocytose Aβ aggregates
por: Yu, Dongqin, et al.
Publicado: (2021)

The Impact of Glycoengineering on the Endoplasmic Reticulum Quality Control System in Yeasts
por: Piirainen, Mari A., et al.
Publicado: (2022)

Simplifying the detection and monitoring of protein glycosylation during in vitro glycoengineering
por: Saunders, Matthew J., et al.
Publicado: (2023)

Key Activating and Inhibitory Ligands Involved in the Mobilization of Natural Killer Cells for Cancer Immunotherapies
por: Karmakar, Surojit, et al.
Publicado: (2021)

Development of a novel glycoengineering platform for the rapid production of conjugate vaccines
por: Abouelhadid, Sherif, et al.
Publicado: (2023)

Safety and immunogenicity of a new glycoengineered vaccine against Acinetobacter baumannii in mice
por: Li, Xin, et al.
Publicado: (2021)

Transient Recombinant Protein Production in Glycoengineered Nicotiana benthamiana Cell Suspension Culture
por: Sukenik, Sara C., et al.
Publicado: (2018)

Investigating Cell Surface Galectin-Mediated Cross-Linking on Glycoengineered Cells
por: Belardi, Brian, et al.
Publicado: (2012)

N-Propionylmannosamine: using biochemical glycoengineering to promote peripheral nerve regeneration
por: Koulaxouzidis, Georgios, et al.
Publicado: (2015)

A novel low-parameter computational model to aid in-silico glycoengineering
por: Spahn, Philipp N, et al.
Publicado: (2015)

Glycoengineered Outer Membrane Vesicles: A Novel Platform for Bacterial Vaccines
por: Price, Nancy L., et al.
Publicado: (2016)

Glycoengineering of AAV-delivered monoclonal antibodies yields increased ADCC activity
por: Termini, James M., et al.
Publicado: (2020)

Application of the Inverse-Electron-Demand Diels-Alder Reaction for Metabolic Glycoengineering
por: Haiber, Lisa Maria, et al.
Publicado: (2021)

Expression and Display of Glycoengineered Antibodies and Antibody Fragments with an Engineered Yeast Strain
por: Shenoy, Anjali, et al.
Publicado: (2021)

Production of galactosylated complex-type N-glycans in glycoengineered Saccharomyces cerevisiae
por: Piirainen, Mari A., et al.
Publicado: (2021)

Rewiring the pneumococcal capsule pathway for investigating glycosyltransferase specificity and genetic glycoengineering
por: Su, Tong, et al.
Publicado: (2023)

Design of Glycoengineered IL-4 Antagonists Employing Chemical and Biosynthetic Glycosylation
por: Thomas, Sarah, et al.
Publicado: (2023)

Natural Killer Cells and Immunotherapy
por: Noh, Ji-Yoon, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b4bm5ipnn3se1fso2rt9ecjstt